Cargando…

Deficiency of Lipocalin-2 Promotes Proliferation and Differentiation of Osteoclast Precursors via Regulation of c-Fms Expression and Nuclear Factor-kappa B Activation

BACKGROUND: Lipocalin-2 (LCN2), a small glycoprotein, has a pivotal role in diverse biological processes such as cellular proliferation and differentiation. We previously reported that LCN2 is implicated in osteoclast formation induced by receptor activator of nuclear factor-kappa B ligand (RANKL) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun-Ju, Ohk, Boram, Kang, Woo Youl, Seong, Sook Jin, Suk, Kyoungho, Lim, Mi-Sun, Kim, Shin-Yoon, Yoon, Young-Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Bone and Mineral Research 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791440/ https://www.ncbi.nlm.nih.gov/pubmed/26981515 http://dx.doi.org/10.11005/jbm.2016.23.1.8

Ejemplares similares

Caveolin-1 regulates osteoclast differentiation by suppressing cFms degradation
por: Lee, Yong Deok, et al.
Publicado: (2015)

Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
por: Arai, Fumio, et al.
Publicado: (1999)

Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice
por: Nara, Yasuhiko, et al.
Publicado: (2020)

Pharmacokinetic and safety evaluation of MB12066, an NQO1 substrate
por: Lee, Hae Won, et al.
Publicado: (2017)

c-Fms Signaling Mediates Neurofibromatosis Type-1 Osteoclast Gain-In-Functions
por: He, Yongzheng, et al.
Publicado: (2012)

Metabolomic analysis of healthy human urine following administration of glimepiride using a liquid chromatography-tandem mass spectrometry
por: Do, Eun Young, et al.
Publicado: (2017)

Determination of sumatriptan in human plasma using liquid chromatography-mass spectrometry for pharmacokinetic study in healthy Korean volunteers
por: Cho, Seungil, et al.
Publicado: (2017)

Neuroinflammation Induced by Transgenic Expression of Lipocalin-2 in Astrocytes
por: Kim, Jae-Hong, et al.
Publicado: (2022)

Regulation of expression level of fms-like tyrosine kinase-4 is related to osteoclast differentiation
por: Zhu, Yi, et al.
Publicado: (2015)

Lipocalin-2 Acts as a Neuroinflammatogen in Lipopolysaccharide-injected Mice
por: Jin, Myungwon, et al.
Publicado: (2014)

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts
por: Lee, Sun Kyoung, et al.
Publicado: (2017)

Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation
por: Lee, Kyunghee, et al.
Publicado: (2017)

Origin of Osteoclasts: Osteoclast Precursor Cells
por: Tsai, Jefferson, et al.
Publicado: (2023)

Modulation of Glial and Neuronal Migration by Lipocalin-2 in Zebrafish
por: Kim, Ho, et al.
Publicado: (2011)

Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy
por: Bhusal, Anup, et al.
Publicado: (2019)

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Pharmacokinetic and bioequivalence study between two formulations of S-1 in Korean gastric cancer patients
por: Lee, Hae Won, et al.
Publicado: (2019)

Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond
por: Bhusal, Anup, et al.
Publicado: (2021)

Corrigendum: Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy
por: Bhusal, Anup, et al.
Publicado: (2019)

Tetrabromobisphenol A Promotes the Osteoclastogenesis of RAW264.7 Cells Induced by Receptor Activator of NF-kappa B Ligand In Vitro
por: Park, So Young, et al.
Publicado: (2019)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Dendrobium moniliforme Exerts Inhibitory Effects on Both Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Bone Erosion in Vivo
por: Baek, Jong Min, et al.
Publicado: (2016)

Increased Plasma Lipocalin-2 Levels in Patients with Myelin Oligodendrocyte Glycoprotein-IgG–Positive Optic Neuritis
por: Kim, Jong-Heon, et al.
Publicado: (2022)

Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo
por: Baek, Jong Min, et al.
Publicado: (2016)

Nuclear factor kappa-B- and activator protein-1-mediated immunostimulatory activity of compound K in monocytes and macrophages
por: Yang, Woo Seok, et al.
Publicado: (2017)

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand
por: Mabilleau, G., et al.
Publicado: (2008)

Receptor activator of nuclear factor-kappa B is enriched in CD9-positive extracellular vesicles released by osteoclasts
por: Ruan, Shaobo, et al.
Publicado: (2023)

Acute Phase Protein Lipocalin-2 Is Associated with Formalin-induced Nociception and Pathological Pain
por: Jha, Mithilesh Kumar, et al.
Publicado: (2013)

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen
por: Zhu, Meiling, et al.
Publicado: (2021)

A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts
por: Kim, Hyun-Ju, et al.
Publicado: (2014)

Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

Carboxypeptidase E Is a Novel Modulator of RANKL-Induced Osteoclast Differentiation
por: Kim, Hyun-Ju, et al.
Publicado: (2014)

ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo
por: Ishizuka, Hisako, et al.
Publicado: (2011)

Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand
por: Kim, Jin-Hee, et al.
Publicado: (2017)

Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

Obatoclax Regulates the Proliferation and Fusion of Osteoclast Precursors through the Inhibition of ERK Activation by RANKL
por: Oh, Ju Hee, et al.
Publicado: (2015)

The quest for a biomarker of circulating osteoclast precursors
por: Ritchlin, Christopher
Publicado: (2009)

Pathological Osteoclasts and Precursor Macrophages in Inflammatory Arthritis
por: Hasegawa, Tetsuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6rqbvsvnh28oj2ihofuj1c18qc